U.S. markets close in 1 hour 59 minutes
  • S&P 500

    3,634.29
    -20.75 (-0.57%)
     
  • Dow 30

    29,045.32
    -215.49 (-0.74%)
     
  • Nasdaq

    10,777.25
    -25.67 (-0.24%)
     
  • Russell 2000

    1,651.70
    -4.19 (-0.25%)
     
  • Crude Oil

    78.81
    +2.10 (+2.74%)
     
  • Gold

    1,637.00
    +3.60 (+0.22%)
     
  • Silver

    18.38
    -0.10 (-0.57%)
     
  • EUR/USD

    0.9589
    -0.0023 (-0.24%)
     
  • 10-Yr Bond

    3.9700
    +0.0920 (+2.37%)
     
  • GBP/USD

    1.0694
    +0.0010 (+0.10%)
     
  • USD/JPY

    144.8560
    +0.1760 (+0.12%)
     
  • BTC-USD

    18,961.32
    -173.29 (-0.91%)
     
  • CMC Crypto 200

    435.39
    -23.74 (-5.17%)
     
  • FTSE 100

    6,984.59
    -36.36 (-0.52%)
     
  • Nikkei 225

    26,571.87
    +140.32 (+0.53%)
     

Global Acne Medication Market to Surpass US$ 13,547.76 Million by 2030 - Coherent Market Insights

·4 min read

SEATTLE, Aug. 26, 2022 /PRNewswire/ -- According to Coherent Market Insights, the global acne medication market is estimated to be valued at US$ 10,382.4 million in 2022 and is expected to exhibit a CAGR of 3.4% during the forecast period (2022-2030).

Coherent Market Insights Logo
Coherent Market Insights Logo

Key Trends and Analysis of the Global Acne Medication Market:

Key companies in the market are focusing on adopting inorganic growth strategies such as acquisitions, which is expected to drive the market growth over the forecast period. For instance, in January 2022, STRATA Skin Sciences, Inc., a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, announced that it entered into a definitive agreement to acquire assets related to Theravant Corporation's TheraClear System. Theravant Corporation develops, produces, markets products for the medical aesthetic marketplace. The company develops and markets a novel, U.S. FDA-cleared, system for the in-office treatment of many common forms of acne. This acquisition will enables STRATA Skin Sciences, Inc., expansion into the acne treatment market.

Request Sample Copy of this Report @ https://www.coherentmarketinsights.com/insight/request-sample/5182

Key Market Takeaways:

The global acne medication market is expected to exhibit a CAGR of 3.4% during the forecast period, owing to the increasing approvals from the regulatory bodies to the key players in the market for the treatment of acne. For instance, on August 8, 2022, Aleor Dermaceuticals, the wholly-owned subsidiary of Alembic Pharmaceuticals, announced that it received final approval from the U.S. Food and Drug Administration for the abbreviated new drug application (ANDA) for adapalene and benzoyl peroxide topical gel of strength 0.3%/2.5% generic topical gel for the treatment of acne vulgaris. The approved ANDA is therapeutically equivalent to the reference listed drug product Epiduo Forte topical gel of GALDERMA LABORATORIES, L.P., a company providing dermatology and skin health services.

Based on formulations, the topical segment is expected to dominate the market growth over the forecast period, as it is the most widely used treatment for acne. For instance, according to the data provided by the American Academy of Pediatrics in May 2020, topical antibiotics can be used in the first-line treatment of acne vulgaris and have additional anti-inflammatory effects.

Among regions, North America is expected to dominate the market growth over the forecast period, owing to the increasing product launch by the key players in the region, to combat the increasing prevalence of acne. For instance, in November 2021, Sun Pharmaceutical Industries, a multinational pharmaceutical company, announced the launch of Winlevi cream, used for the treatment of acne vulgaris in patients 12 years and older, in the U.S. market.

Key players operating in the global acne medication market include GALDERMA LABORATORIES, L.P., Reckitt Benckiser Group PLC, Valeant Pharmaceuticals, Bayer AG, GlaxoSmithKline, Almirall, S.A, Bausch Health Companies Inc., Mylan N.V., Sun Pharmaceutical Industries, Inc., Pfizer Inc., Teva Pharmaceutical Industries Ltd., and Allergan.

Request for Customization @ https://www.coherentmarketinsights.com/insight/request-customization/5182

Detailed Segmentation:

Global Acne Medication Market, By Formulation:

Global Acne Medication Market, By Product Type:

Global Acne Medication Market, By Type:

Global Acne Medication Market, By Acne Type:

Global Acne Medication Market, By Distribution Channel:

Global Acne Medication Market, By Region:

  • North America

  • Europe

  • Asia Pacific

  • Latin America

  • Middle East & Africa

Buy this Complete Report Now @ https://www.coherentmarketinsights.com/insight/buy-now/5182

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having sales office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 57 countries worldwide. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.

Contact Us: 
Mr. Shah 
Senior Client Partner – Business Development 
Coherent Market Insights 
Phone: 
US: +1-206-701-6702 
UK: +44-020-8133-4027 
Japan: +81-050-5539-1737 
India: +91-848-285-0837 
Email: sales@coherentmarketinsights.com 
Website: https://www.coherentmarketinsights.com
Follow Us: LinkedInTwitter

Logo: https://mma.prnewswire.com/media/902389/Coherent_Market_Insights_Logo.jpg

Cision
Cision

View original content:https://www.prnewswire.com/news-releases/global-acne-medication-market-to-surpass-us-13-547-76-million-by-2030--coherent-market-insights-301613009.html

SOURCE Coherent Market Insights